Stryker's Synchfix EVT Revolutionizes Ankle Injury Treatment with Screwless Fixation

Stryker's Synchfix EVT Revolutionizes Ankle Injury Treatment with Screwless Fixation

An old book with a drawing of a foot on the cover, containing text and a detailed diagram of the foot's anatomy, specifically the ankle.

Stryker's Synchfix EVT Revolutionizes Ankle Injury Treatment with Screwless Fixation

Stryker has unveiled Synchfix EVT, a next-generation flexible device for ankle syndesmosis injuries. The system aims to simplify surgery while improving stability for patients with soft tissue or bone damage. It is the first such device cleared for use in adolescents, broadening treatment options for younger individuals.

The new technology has already earned recognition, winning the Red Dot Design Award for its innovative, all-in-one design. Stryker is now showcasing the device at the 2026 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting with live demonstrations.

Synchfix EVT builds on Stryker's existing Synchfix platform but reduces procedural complexity compared to earlier models. The system features an ergonomic handle and a low-profile titanium implant for easier surgical use. Its one-handed deployment design and integrated suture tensioning handles streamline the process for surgeons.

The device addresses common challenges in syndesmosis injuries, including malreduction (occurring in up to 50% of cases) and screw loosening or breakage (affecting 10-30% of patients). Unlike traditional screw-based fixation, Synchfix EVT uses a dynamic, screwless approach with elastic anchoring. This method supports natural ankle movement, lowers the risk of malreduction, and eliminates loosening concerns.

Intended for both soft tissue and bone fixation, the system can be used in ankle syndesmosis disruptions—with or without fractures—as well as alongside hardware for fracture repair. Its flexible design allows for controlled movement, reducing the need for secondary operations, which currently affect up to 20% of patients.

As a global leader in medical technologies, Stryker specialises in orthopaedics, neurotechnology, and surgical solutions. The company's latest innovation reflects its focus on improving patient outcomes through advanced engineering and user-friendly designs.

Synchfix EVT offers a simpler, more adaptable solution for ankle syndesmosis injuries. Its screwless, elastic fixation aims to reduce complications while supporting natural joint function. The device is now available for surgeons, with Stryker highlighting its benefits at this year's ACFAS conference.

Neueste Nachrichten